SCHEMBL6473593

SCHEMBL6473593

CCI.CCOc1c(Cl)cccc1C=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ KMT2A Q03164 3/20 0.38
▸ ALDH1A1 P00352 5/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ ERN1 O75460 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ ORAI1 Q96D31 1/20 0.34
▸ GSK3A P49840 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1253929 0.95 L3MBTL1 (0.44) L3MBTL1CA1CA2KMT2AALDH1A1
SCHEMBL1299322 0.90 ERN1 (0.41) L3MBTL1CA1CA2KMT2AALDH1A1
SCHEMBL1254363 0.83 ALDH1A1 (0.43) L3MBTL1CA1CA2KMT2AALDH1A1
SCHEMBL5255681 0.81 ERN1 (0.41) L3MBTL1CA1CA2KMT2AALDH1A1
SCHEMBL3808547 0.78 KMT2A (0.41) CA1CA2KMT2AALDH1A1MEN1
SCHEMBL16958358 0.78 ALDH1A1 (0.48) L3MBTL1KMT2AALDH1A1MEN1GAA
SCHEMBL16950330 0.78 L3MBTL1 (0.44) L3MBTL1KMT2AALDH1A1MEN1GAA
SCHEMBL23696963 0.78 ALDH1A1 (0.50) L3MBTL1KMT2AALDH1A1MEN1GAA
SCHEMBL30304089 0.77 HPGD (0.44) L3MBTL1CA1CA2KMT2AALDH1A1
SCHEMBL1547567 0.76 L3MBTL1 (0.59) L3MBTL1KMT2AALDH1A1MEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575951-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY Affinium Pharmaceuticals, Inc. (CA) 2005-09-21 — — EP disclosed
WO-2004052890-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY AFFINIUM PHARMACEUTICALS, INC. (CA) 2004-06-24 — — WO disclosed
Send feedback